ORTOMA AB (PUBL) Financials Ortoma AB (publ) NORDIC GROWTH MARKET
Equities
ORT B
SE0005676103
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.76 SEK | +1.41% |
|
+3.60% | -22.16% |
| Feb. 20 | Ortoma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Feb. 20 | Ortoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 146.7 | 361.2 | 361.2 | - |
| Enterprise Value (EV) 1 | 146.7 | 320.7 | 308.9 | 334.2 |
| P/E ratio | -9.37 x | -9.55 x | 19.5 x | -12.2 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 9.75 x | 4.1 x | 6.12 x |
| EV / Revenue | - | 8.41 x | 3.51 x | 5.66 x |
| EV / EBITDA | - | -20.3 x | 9.33 x | -21.2 x |
| EV / FCF | - | -30.3 x | 309 x | -12.9 x |
| FCF Yield | - | -3.3% | 0.32% | -7.78% |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 19,821 | 37,084 | 37,084 | - |
| Reference price 2 | 7.400 | 9.740 | 9.740 | 9.740 |
| Announcement Date | 1/20/23 | 2/20/24 | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | 38.14 | 88.1 | 59 |
| EBITDA 1 | - | -15.83 | 33.1 | -15.8 |
| EBIT 1 | - | -21.98 | 19.1 | -29.8 |
| Operating Margin | - | -57.64% | 21.68% | -50.51% |
| Earnings before Tax (EBT) 1 | - | -21.87 | 18 | -31 |
| Net income 1 | -15.75 | -21.87 | 18 | -31 |
| Net margin | - | -57.35% | 20.43% | -52.54% |
| EPS 2 | -0.7900 | -1.100 | 0.5000 | -0.8000 |
| Free Cash Flow 1 | - | -10.59 | 1 | -26 |
| FCF margin | - | -27.76% | 1.14% | -44.07% |
| FCF Conversion (EBITDA) | - | - | 3.02% | - |
| FCF Conversion (Net income) | - | - | 5.56% | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 1/20/23 | 2/20/24 | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|
| Net sales 1 | 25.09 | 10.3 | 15.6 |
| EBITDA 1 | 13.14 | -0.627 | -24.53 |
| EBIT 1 | 13.12 | -1.9 | -29.37 |
| Operating Margin | 52.27% | -18.44% | -188.3% |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 8/22/23 | 10/26/23 | 2/20/24 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 51.2 | 52.3 | 27 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | -10.6 | 1 | -26 |
| ROE (net income / shareholders' equity) | - | -15.2% | 10% | -18% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | - | - | 1 |
| Capex / Sales | - | - | - | 1.69% |
| Announcement Date | 1/20/23 | 2/20/24 | - | - |
1SEK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.31% | 32.15B | |
| +17.27% | 7.41B | |
| +21.60% | 3.85B | |
| -17.44% | 3.13B | |
| -27.80% | 1.25B | |
| -31.01% | 1.17B | |
| -34.81% | 911M | |
| +3.51% | 926M | |
| -25.45% | 842M |
- Stock Market
- Equities
- ORT B Stock
- ORT B Stock
- Financials Ortoma AB (publ)
